Skip to content

Avantor AVTR Cash & Equivalents

Cash & Equivalents at other companies

Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
$3.28B-21.4%
Danaher logo
DanaherDHR
$5.7B+186%
Agilent Technologies logo
Agilent TechnologiesA
$1.81B+21.5%
West Pharmaceutical Services logo
West Pharmaceutical ServicesWST
$521.4M+29.0%
Element Solutions logo
Element SolutionsESI
$177.3M-64.5%
Westlake logo
WestlakeWLK
$2.29B-1.1%

Other financials

Income statement

See full
Revenue$1.6B0.0%
Gross profit$500.7M-6.4%
Operating income$99.5M-32.5%
Net income$43.3M-32.9%
EPS (diluted)$0.06-33.3%

Balance sheet

See full
Total debt$3.8B-7.1%
Total equity$5.6B-8.4%
Total assets$11.7B-5.4%

Cash flow

See full
Operating cash flow$58.7M-46.3%
CapEx$33.5M+19.6%
Free cash flow$25.2M-69.0%

Valuation

See full
Market cap$6.54B-52.0%
Enterprise value$10.07B-40.4%
P/S-1.0×

Profitability

See full
Gross margin32.1%-1.4pp
Operating margin4%-5.2pp
Net margin-9.2%-19.9pp
FCF margin6.7%-3.3pp

Returns & leverage

See full
Return on equity-10.3%-22.8pp
Debt / equity0.7×0.0×
Current ratio1.8×+0.6×

Where this comes from

Reported directly by Avantor in its filing.

Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents.

The official record: Avantor’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →

Ask your AI about Avantor's cash & equivalents.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Avantor's cash & equivalents?
Avantor (AVTR) reported cash & equivalents of $282.2M in Q1 2026.
How has Avantor's cash & equivalents changed year-over-year?
Avantor's cash & equivalents decreased by 11.4% year-over-year, from $318.5M to $282.2M.
What is the long-term trend for Avantor's cash & equivalents?
Over 5 years (2020 to 2025), Avantor's cash & equivalents has grown at a 5.0% compound annual growth rate (CAGR), from $289.2M to $368.3M.
What does cash & equivalents mean?
Cash on hand plus highly liquid investments with maturities of three months or less at purchase — treasury bills, money market funds, and commercial paper.